223 related articles for article (PubMed ID: 30026411)
1. [Analysis of Fecal Cancer-Specific DNA to Detect Colorectal Neoplasia].
Nagasaka T; Yamaguchi Y
Gan To Kagaku Ryoho; 2018 Jun; 45(6):906-910. PubMed ID: 30026411
[TBL] [Abstract][Full Text] [Related]
2. [Chemical or immunological tests for the detection of fecal occult blood in colorectal cancer screening?].
Quintero E
Gastroenterol Hepatol; 2009 Oct; 32(8):565-76. PubMed ID: 19577340
[TBL] [Abstract][Full Text] [Related]
3. Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer.
Robertson DJ; Lee JK; Boland CR; Dominitz JA; Giardiello FM; Johnson DA; Kaltenbach T; Lieberman D; Levin TR; Rex DK
Am J Gastroenterol; 2017 Jan; 112(1):37-53. PubMed ID: 27753435
[TBL] [Abstract][Full Text] [Related]
4. [Fecal Biomarker for Colorectal Cancer Diagnosis].
Koga Y; Yamazaki N; Matsumura Y
Rinsho Byori; 2015 Mar; 63(3):361-8. PubMed ID: 26524859
[TBL] [Abstract][Full Text] [Related]
5. Is fecal occult blood testing more sensitive for left- versus right-sided colorectal neoplasia? A systematic literature review.
Haug U; Knudsen AB; Brenner H; Kuntz KM
Expert Rev Mol Diagn; 2011 Jul; 11(6):605-16. PubMed ID: 21745014
[TBL] [Abstract][Full Text] [Related]
6. Gene expression analysis using a highly sensitive DNA microarray for colorectal cancer screening.
Koga Y; Yamazaki N; Takizawa S; Kawauchi J; Nomura O; Yamamoto S; Saito N; Kakugawa Y; Otake Y; Matsumoto M; Matsumura Y
Anticancer Res; 2014 Jan; 34(1):169-76. PubMed ID: 24403458
[TBL] [Abstract][Full Text] [Related]
7. Patient perceptions of stool-based DNA testing for colorectal cancer screening.
Schroy PC; Heeren TC
Am J Prev Med; 2005 Feb; 28(2):208-14. PubMed ID: 15710277
[TBL] [Abstract][Full Text] [Related]
8. Fecal DNA for noninvasive diagnosis of colorectal cancer in immunochemical fecal occult blood test-positive individuals.
Calistri D; Rengucci C; Casadei Gardini A; Frassineti GL; Scarpi E; Zoli W; Falcini F; Silvestrini R; Amadori D
Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2647-54. PubMed ID: 20929882
[TBL] [Abstract][Full Text] [Related]
9. Use of faecal markers in screening for colorectal neoplasia: a European group on tumor markers position paper.
Duffy MJ; van Rossum LG; van Turenhout ST; Malminiemi O; Sturgeon C; Lamerz R; Nicolini A; Haglund C; Holubec L; Fraser CG; Halloran SP
Int J Cancer; 2011 Jan; 128(1):3-11. PubMed ID: 20824704
[TBL] [Abstract][Full Text] [Related]
10. Lower risk of advanced neoplasia among patients with a previous negative result from a fecal test for colorectal cancer.
Denters MJ; Deutekom M; Bossuyt PM; Stroobants AK; Fockens P; Dekker E
Gastroenterology; 2012 Mar; 142(3):497-504. PubMed ID: 22108194
[TBL] [Abstract][Full Text] [Related]
11. Fecal DNA biomarkers for the detection of colorectal neoplasia: attractive, but is it feasible?
Brenner DE; Rennert G
J Natl Cancer Inst; 2005 Aug; 97(15):1107-9. PubMed ID: 16077063
[No Abstract] [Full Text] [Related]
12. Faecal occult blood testing for colorectal cancer screening: the past or the future.
Benton SC; Seaman HE; Halloran SP
Curr Gastroenterol Rep; 2015 Feb; 17(2):428. PubMed ID: 25673567
[TBL] [Abstract][Full Text] [Related]
13. Colon cancer screening strategies.
Agrawal J; Syngal S
Curr Opin Gastroenterol; 2005 Jan; 21(1):59-63. PubMed ID: 15687886
[TBL] [Abstract][Full Text] [Related]
14. Early detection of colorectal cancer with faecal occult blood test screening.
Paimela H; Malila N; Palva T; Hakulinen T; Vertio H; Järvinen H
Br J Surg; 2010 Oct; 97(10):1567-71. PubMed ID: 20603855
[TBL] [Abstract][Full Text] [Related]
15. Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer.
Robertson DJ; Lee JK; Boland CR; Dominitz JA; Giardiello FM; Johnson DA; Kaltenbach T; Lieberman D; Levin TR; Rex DK
Gastroenterology; 2017 Apr; 152(5):1217-1237.e3. PubMed ID: 27769517
[TBL] [Abstract][Full Text] [Related]
16. Is fecal DNA testing superior to fecal occult-blood testing for colorectal cancer screening?
Capellá G
Nat Clin Pract Oncol; 2005 May; 2(5):234-5. PubMed ID: 16264954
[No Abstract] [Full Text] [Related]
17. Fecal occult blood testing.
Sanford KW; McPherson RA
Clin Lab Med; 2009 Sep; 29(3):523-41. PubMed ID: 19840685
[TBL] [Abstract][Full Text] [Related]
18. [Fecal methylated DNA for the detection of colorectal cancer].
von Delius S; Jung A; Schmid RM
Z Gastroenterol; 2006 Sep; 44(9):1001-2. PubMed ID: 16981074
[No Abstract] [Full Text] [Related]
19. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia.
Smith A; Young GP; Cole SR; Bampton P
Cancer; 2006 Nov; 107(9):2152-9. PubMed ID: 16998938
[TBL] [Abstract][Full Text] [Related]
20. [Gene methylation in stool for the screening of colorectal cancer and pre-malignant lesions].
Kang YP; Cao FA; Chang WJ; Lou Z; Wang H; Wu LL; Fu CG; Cao GW
Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Jan; 14(1):52-6. PubMed ID: 21271382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
